• A Case Series of Rheumatoid Arthritis Flare Including Extra-articular Manifestations Following SARS-CoV-2 mRNA Vaccination: A Comprehensive Cytokine Assay
• Acute Necrotizing Encephalitis Due to Influenza B in a Child: A Case Report
• Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
• Are herbal medications, with possible beneficial effects for benign prostatic hyperplasia, better to be continued during the COVID-19 pandemic?
• Association of the <em>IFNG</em> +874T/A Polymorphism with Symptomatic COVID-19 Susceptibility
• Bacteria-Associated Cytokine Storm Syndrome
• Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial
• C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
• Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment
• Clinical Features of Cytokine Storm Syndrome
• COVID-19 Pneumonia and Cytokine Storm Syndrome
• COVID-19 Related Predisposition to Diabetic Ketoacidosis
• Criteria for Cytokine Storm Syndromes
• Cytokine storm syndrome after anti-thymoglobulin infusion in a cynomolgus monkey with systemic lymphadenopathy caused by follicular hyperplasia: A case report
• Cytokine Storm Syndrome as a Manifestation of Primary HIV Infection
• Cytokine Storm Syndrome Associated with Hemorrhagic Fever and Other Viruses
• Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis
• Cytokine Storm Syndrome Responsive to IL-1 Inhibition in Trisomy 21
• Cytokine Storm Syndrome Triggered by Extracorporeal Membrane Oxygenation in Pediatric Patients
• Cytokines in Cytokine Storm Syndrome
• Development of Acute Transverse Myelitis following COVID-19 Infection: A Review on the Potential Pathways
• Disparate macrophage responses are linked to infection outcome of Hantan virus in humans or rodents
• Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial
• Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review
• Establishing thresholds for cytokine storm and defining their relationship to disease severity in respiratory viral infections
• Etoposide Therapy of Cytokine Storm Syndromes
• Etoposide: A rider on the cytokine storm
• Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
• Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
• Fraxin in Combination with Dexamethasone Attenuates LPS-Induced Liver and Heart Injury and Their Anticytokine Activity in Mice
• Genetics of Acquired Cytokine Storm Syndromes : Secondary HLH Genetics
• Hemodialysis: The Life Boat for AKI Patients in the COVID Cytokine Storm
• Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases
• High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells
• History of Hemophagocytic Lymphohistiocytosis
• HLA-II-Dependent Neuroimmune Changes in Group A Streptococcal Necrotizing Fasciitis
• Hypocomplementemic urticarial vasculitis case with hemophagocytic lymphohistiocytosis following SARS-CoV-2 mRNA vaccination
• Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report
• IL-1 Family Blockade in Cytokine Storm Syndromes
• IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo
• Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations
• Impact of plasmapheresis on severe COVID-19
• Impact of the MCP-1-2518A&gt;G polymorphism on COVID-19 severity in the Iranian population: A case-control study
• In the Eye of the Cytokine Storm: A Tale of SARS-CoV-2-Induced Acute Macular Neuroretinopathy
• Inborn Errors of Immunity and Cytokine Storm Syndromes
• Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
• Introduction
• Kawasaki disease cytokine release syndrome and Kawasaki disease shock syndrome: A case report
• Kawasaki Disease-Associated Cytokine Storm Syndrome
• Leucine alleviates cytokine storm syndrome by regulating macrophage polarization via the mTORC1/LXRalpha signaling pathway
• Mechanism of new coronavirus pneumonia agreement prescription on 2019 novel coronavirus-infected pneumonia based on network pharmacology analysis and the validation
• MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases
• MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?
• Modeling mechanisms underlying differential inflammatory responses to COVID-19 in type 2 diabetes using a patient-derived microphysiological organ-on-a-chip system
• Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2
• Neutrophil-macrophage communication via extracellular vesicle transfer promotes itaconate accumulation and ameliorates cytokine storm syndrome
• NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases-A Lesson from Cytokine Storm Syndrome
• Parasitic and Fungal Triggers of Cytokine Storm Syndrome
• Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial
• Photobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish Model
• Plasma Nitric Oxide Consumption Is Elevated and Associated With Adverse Outcomes in Critically Ill Patients
• Polyphosphazene nanodrugs for targeting delivery and inflammation responsive release of curcumin to treat acute lung injury by effectively inhibiting cytokine storms
• Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review
• Possible Toxin-Induced Acute Necrotising Encephalitis (ANE) With Secondary Vasculopathy and Paroxysmal Autonomic Instability With Dystonia (PAID) Syndrome
• Potential therapeutic value of necroptosis inhibitor for the treatment of COVID-19
• Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm
• Pyruvate Kinase M2 Nuclear Translocation Regulate Ferroptosis-Associated Acute Lung Injury in Cytokine Storm
• Rational Design of Chemically Controlled Antibodies and Protein Therapeutics
• Role of Endothelium in Cardiovascular Sequelae of Long COVID
• Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis
• SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
• SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs
• Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary
• Selected severe &amp;#8222;haematological&amp;#8220; syndromes in adult intensive care patients
• Serum proteomics reveals hemophagocytic lymphohistiocytosis-like phenotype in a subset of patients with multisystem inflammatory syndrome in children
• Severe COVID-19-Induced Hemophagocytic Lymphohistiocytosis
• Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more
• Small molecule inhibitor CRT0066101 inhibits cytokine storm syndrome in a mouse model of lung injury
• Tetrastigma hemsleyanum polysaccharide ameliorates cytokine storm syndrome via the IFN-gamma-JAK2/STAT pathway
• The mechanistic basis linking cytokine storm to thrombosis in COVID-19
• The Multifaceted Immunology of Cytokine Storm Syndrome
• The NLRP3 inflammasome is essential for IL-18 production in a model of macrophage activation syndrome
• The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome
• The redirected killing of PD-L1 positive tumor cells by the expanded mucosa-associated invariant T (MAIT) cells is mediated with a bispecific antibody targeting TCR Vα7.2 and PD-L1
• The Relationship Between COVID-19 and the Development of Depression: Implications on Mental Health
• The role of continuous renal replacement therapy (Crrt) in Coronavirus disease 2019 (Covid-19) patients
• The Role of the Plasminogen/Plasmin System in Inflammation of the Oral Cavity
• The Scutellaria-Coptis herb couple and its active small-molecule ingredient wogonoside alleviate cytokine storm by regulating the CD39/NLRP3/GSDMD signaling pathway
• The Trend of C-Reactive Protein After Corticosteroid Therapy in COVID-19 Patients Admitted to IGIMS, Patna
• Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19
• Three-month follow-up after severe COVID-19 infection: are chest CT results associated with respiratory outcomes and respiratory recovery in COVID-19 patients?
• Thrombosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children: Retrospective Cohort Study Analysis and Review of the Literature
• Tmem178 negatively regulates IL-1β production through inhibition of the NLRP3 inflammasome
• Tmem178 Negatively Regulates IL-1β Production Through Inhibition of the NLRP3 Inflammasome
• Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children
• Transforming Growth Factor-β1 C (+869) T Codon 10 Gene Polymorphism Significantly Associated with Rates of SARS-CoV-2 in Kidney Transplant Recipients in Kuwait
• Use of therapeutic plasma exchange in COVID-19: A systematic review of current evidence
• What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms
• Zoonotic Bacterial Infections Triggering Cytokine Storm Syndrome
• Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19